Cell viability assays and colony formation assays demonstrated that BT474 cells were more resistant to tamoxifen than T47D cells (Fig. 1b–d), indicating that breast cancer cells with HER2 overexpression were resistant to tamoxifen. The gene discussed is ERBB2; the disease is breast cancer.